RecruitingPhase 2NCT04028063

Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas

Studying Soft tissue sarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Colorado, Denver
Principal Investigator
Breelyn Wilky, MD
University of Colorado, Denver
Intervention
Balstilimab(drug)
Enrollment
65 target
Eligibility
18-100 years · All sexes
Timeline
2020 – 2027

Study locations (1)

Collaborators

Agenus Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04028063 on ClinicalTrials.gov

Other trials for Soft tissue sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Soft tissue sarcoma →

← Back to all trials